Countries differ widely in the types of human biotechnologies they regulate,
the jurisdiction of authority, the nature of enforcement, and other
particulars. One requirement for effective policy is a government agency
responsible for licensing and monitoring research and commercial facilities
that work with human embryos. Frequently cited models are Canada's Assisted Human Reproduction Act and the United Kingdomís
Human Fertilization and Embryology Authority (HFEA).
How iPS cells changed the worldby Megan Scudellari, NatureJune 15th, 2016Though therapies using induced pluripotent stem cells have proved challenging, iPS cells have become important for modelling and investigating human diseases, as well as for screening drugs.